Data holes could complicate Moderna and J&J booster shot process

J&J recently put out a press release outlining results from its clinical trials evaluating a second shot two and six months after the first.

But it’s unclear whether the full six-month data will be available by the time the FDA reviews J&J boosters, according to a source familiar with discussions. A second source familiar with the situation said the full clinical trial results of a second J&J dose after six months aren’t expected until early November.

That could be problematic, as six months is more reflective of the gap between doses most J&J recipients would have. “Most of those people who got the one-shot and done — they’re well past two months right now,” Topol said. “So what does this mean?”